Efficacy, Safety and Pharmacokinetics of Indacaterol in Caucasian and Japanese Patients with Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy, Safety and Pharmacokinetics of Indacaterol in Caucasian and Japanese Patients with Chronic Obstructive Pulmonary Disease

Published:2011-04 Issue:4 Volume:31 Page:247-255
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clinical Drug Investigation

Author:

Hosoe Motoi,Woessner Ralph,Matsushima Soichiro,Lawrence David,Kramer Benjamin

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Reference13 articles.

1. Ultra long-acting β2-agonists in development for asthma and chronic obstructive pulmonary disease

2. Safety, tolerability and efficacy of indacaterol, a novel once-daily β2-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial

3. A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison

4. The Role of Ethnicity in Variability in Response to Drugs: Focus on Clinical Pharmacology Studies

5. A Note on Ethnic Sensitivity Studies

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic considerations surrounding triple therapy for uncontrolled asthma;Expert Opinion on Drug Metabolism & Toxicology;2023-06-03

2. Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects;BMC Pulmonary Medicine;2021-01-07

3. A comparison of tiotropium/olodaterol vs tiotropium alone in terms of treatment effect for chronic obstructive pulmonary disease;Medicine;2020-04

4. Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives;Advances in Therapy;2019-02-11

5. Pulmonary drug delivery to older people;Advanced Drug Delivery Reviews;2018-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3